Drugmakers gear up to copy biotech drugs in U.S.

to 45 percent with two to three competitors for each brand-name drug. David Snow, Chief Executive Officer at Medco Health Solutions Inc (MHS.N "Over 40 different compounds are in development right now tied to many, many different manufacturers," he said....